RightFit Trial Directory

Type 2 Diabetes clinical trials in San Antonio, TX

33 recruiting type 2 diabetes studies with a site in San Antonio, TX.

All trials in San Antonio, TX · All Type 2 Diabetes trials

RecruitingPhase 3NCT07654374

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics

Austin, TX · Farmers Branch, TX · Houston, TX · +71 more sites

RecruitingPhase 3NCT07064473

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

Sponsor: Boehringer Ingelheim

Austin, TX · Brownsville, TX · +205 more sites

RecruitingPhase 3NCT07351045

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

Sponsor: Hoffmann-La Roche

Bellaire, TX · Brownsville, TX · Corpus Christi, TX · +41 more sites

RecruitingPhase 2NCT07589608

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

Sponsor: Eli Lilly and Company

Austin, TX · Dallas, TX · Houston, TX · +37 more sites

RecruitingPhase 2NCT07668388

A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes

Sponsor: Novo Nordisk A/S

Austin, TX · Houston, TX · Lampasas, TX · +22 more sites

RecruitingNot applicableNCT07864168

Evaluation of MiniMed Next Generation Extended Wear Sensors and Algorithm in Patients With Type 1 and Type 2 Diabetes

Sponsor: Medtronic MiniMed, Inc.

Austin, TX · San Antonio, TX · +16 more sites

RecruitingPhase 1NCT06562907

Study of GS-4571 in Healthy Participants, Nondiabetic Obese Participants, and Nonobese Participants With Type 2 Diabetes Mellitus (T2DM)

Sponsor: Gilead Sciences

San Antonio, TX · +2 more sites

RecruitingPhase 4NCT06706284

Glycemic and Weight Loss Effects of GLP-1R Agonist Therapy in Subjects With Spinal Cord Injury and Type 2 Diabetes

Sponsor: Marzieh Salehi

San Antonio, TX

RecruitingPhase 3NCT07564414

A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight

Sponsor: Novo Nordisk A/S

Amarillo, TX · Austin, TX · +96 more sites

RecruitingNot applicableNCT02969798

Pre-diabetes in Subject With Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT)

Sponsor: The University of Texas Health Science Center at San Antonio

San Antonio, TX

RecruitingPhase 4NCT05838287

Pioglitazone on Heart Failure in Type-2 Diabetes Mellitus Participants

Sponsor: The University of Texas Health Science Center at San Antonio

San Antonio, TX

RecruitingPhase 3NCT07321886

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

Sponsor: Eli Lilly and Company

Bellaire, TX · Dallas, TX · +38 more sites

RecruitingPhase 3NCT07392190

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

Sponsor: Eli Lilly and Company

Dallas, TX · Houston, TX · Kingwood, TX · +56 more sites

RecruitingPhase 3NCT07784270

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

Sponsor: AstraZeneca

DeSoto, TX · El Paso, TX · Houston, TX · +51 more sites

RecruitingPhase 1 / Phase 2NCT05267626

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

Sponsor: Aulos Bioscience, Inc.

Austin, TX · Houston, TX · San Antonio, TX · +7 more sites

RecruitingPhase 3NCT07743450

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

Sponsor: Ascletis Pharma (China) Co., Limited

Austin, TX · Brownsville, TX · DeSoto, TX · +81 more sites

RecruitingPhase 2NCT07340320

A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus

Sponsor: Corxel Pharmaceuticals

Dallas, TX · Mesquite, TX · +31 more sites

RecruitingPhase 3NCT07662213

A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus

Sponsor: AstraZeneca

Dallas, TX · Houston, TX · +61 more sites

RecruitingPhase 3NCT07662135

A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin

Sponsor: AstraZeneca

San Antonio, TX · +31 more sites

RecruitingPhase 3NCT07662109

A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus

Sponsor: AstraZeneca

Dallas, TX · McKinney, TX · Paris, TX · +37 more sites

RecruitingPhase 3NCT07784725

A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

Sponsor: AstraZeneca

Houston, TX · San Antonio, TX · Sugar Land, TX · +30 more sites

RecruitingPhase 1NCT07024823

A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4248 in Healthy Participants and Participants With Chronic Kidney Disease and Type 2 Diabetes and to Assess Home Measurements of Creatinine in a Non Interventional Cohort

Sponsor: AstraZeneca

San Antonio, TX · +4 more sites

RecruitingNot applicableNCT07674628

SALUD-M: Acceptance Based Coping Skills for Hispanic/Latinx Military Patients With Type 2 Diabetes

Sponsor: Baylor College of Medicine

San Antonio, TX

RecruitingPhase 1NCT05960656

SGLTi, Hepatic Glucose Production and Ketogenesis

Sponsor: The University of Texas Health Science Center at San Antonio

San Antonio, TX

RecruitingEarly Phase 1NCT07053293

SGLT2i, Hepatic Glucose Production, and SNS

Sponsor: The University of Texas Health Science Center at San Antonio

San Antonio, TX

RecruitingPhase 1NCT07053306

SGLT2i, Ketoacidosis, Volume Contraction, and Insulinopenia

Sponsor: The University of Texas Health Science Center at San Antonio

San Antonio, TX

RecruitingPhase 1NCT07053319

SGLT2i, Pioglitazone, and Ketone Production in T2D

Sponsor: The University of Texas Health Science Center at San Antonio

San Antonio, TX

RecruitingPhase 2NCT07502508

Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy

Sponsor: Biomea Fusion Inc.

Austin, TX · Dallas, TX · Houston, TX · +14 more sites

RecruitingPhase 2NCT07546929

HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes

Sponsor: Housey Healthcare ULC

Dallas, TX · Irving, TX · Lewisville, TX · +22 more sites

RecruitingNot applicableNCT07518004

ROME GS System Study

Sponsor: Senseonics, Inc.

San Antonio, TX · +3 more sites

RecruitingPhase 2NCT06717698

A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease

Sponsor: Novo Nordisk A/S

El Paso, TX · San Antonio, TX · +15 more sites

RecruitingEarly Phase 1NCT06108076

Acute and Chronic Effects of Oral Ketones in Subjects With HFrEF and Diabetes

Sponsor: The University of Texas Health Science Center at San Antonio

San Antonio, TX

Not yet recruitingPhase 3NCT07881458

A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes

Sponsor: Eli Lilly and Company

Austin, TX · Fort Worth, TX · Houston, TX · +22 more sites

Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.